Literature DB >> 4930209

Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.

G A Currie, F Lejeune, G H Fairley.   

Abstract

A microculture technique has been adapted to assay the cytotoxic properties of the lymphocytes from patients with malignant melanoma when cultured with their autologous tumour cells. In a series of patients with established melanoma specific autologous cytotoxicity was extremely uncommon, being detectable in only 3 out of the 22 cases studied. This cytotoxicity did not correlate with clinical staging of the disease but may well have been related to tumour volume. By autoimmunization of patients with an irradiated suspension of their own tumour cells the appearance of cytotoxic lymphocytes could be provoked in 5 out of the 12 patients studied. This cytotoxicity was detectable at the end of the first week after the autograft and disappeared by the third week. Cytotoxic lymphocytes did not correlate in any obvious way with the appearance of specific antitumour antibodies detected by immunofluorescence. So far there has been no evidence of a serum factor capable of blocking the lymphocyte cytotoxicity in these patients.The presence and possible significance of cytotoxic lymphocytes in patients with malignant disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4930209      PMCID: PMC1796103          DOI: 10.1136/bmj.2.5757.305

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  14 in total

1.  The effect of vaccine on cancer patients.

Authors:  J B GRAHAM; R M GRAHAM
Journal:  Surg Gynecol Obstet       Date:  1959-08

2.  Applications of immunology to clinical cancer. Past attempts and future possibilities.

Authors:  C M SOUTHAM
Journal:  Cancer Res       Date:  1961-10       Impact factor: 12.701

3.  The cellular immune response to primary sarcomata in rats. II. Abnormal responses of nodes draining the tumour.

Authors:  P Alexander; J Bensted; E J Delorme; J G Hall; J Hodgett
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-11-18

4.  Cellular and humoral immunity to different types of human neoplasms.

Authors:  I Hellström; K E Hellström; G E Pierce; J P Yang
Journal:  Nature       Date:  1968-12-28       Impact factor: 49.962

5.  Demonstration of antibodies against human malignant melanoma by immunofluorescence.

Authors:  D L Morton; R A Malmgren; E C Holmes; A S Ketcham
Journal:  Surgery       Date:  1968-07       Impact factor: 3.982

6.  Search for host defenses in Burkitt lymphoma: membrane immunofluorescence tests on biopsies and tissue culture lines.

Authors:  G Klein; E Klein; P Clifford
Journal:  Cancer Res       Date:  1967-12       Impact factor: 12.701

7.  A microassay for cell-mediated immunity.

Authors:  M Takasugi; E Klein
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

8.  Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia.

Authors:  W H Fridman; F M Kourilsky
Journal:  Nature       Date:  1969-10-18       Impact factor: 49.962

9.  Cellular and subcellular differentiation of melanin phagocytosis and synthesis by lysosomal and melanosomal activity.

Authors:  Y Mishima
Journal:  J Invest Dermatol       Date:  1966-01       Impact factor: 8.551

10.  Autoimmunization with irradiated tumour cells in human malignant melanoma.

Authors:  R L Ikonopisov; M G Lewis; I D Hunter-Craig; D C Bodenham; T M Phillips; C I Cooling; J Proctor; G H Fairley; P Alexander
Journal:  Br Med J       Date:  1970-06-27
View more
  30 in total

Review 1.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 2.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

3.  The role of circulating antibody in the control of metastases.

Authors:  M G Lewis
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

4.  Effect of autoimmunization with irradiated tumour cells on specific cell-mediated immunity in patients with malignant melanoma.

Authors:  G A Currie
Journal:  Proc R Soc Med       Date:  1972-02

5.  Immune therapy of malignant melanoma.

Authors: 
Journal:  Can Med Assoc J       Date:  1972-09-09       Impact factor: 8.262

6.  Cellular immunity to breast carcinoma and malignant melanoma.

Authors:  A J Cochran; R M Mackie; C E Thomas; R M Grant; D E Cameron-Mowat; W G Spilg
Journal:  Br J Cancer Suppl       Date:  1973-08

7.  The role of circulating antigen as an inhibitor of tumour immunity in man.

Authors:  G Currie
Journal:  Br J Cancer Suppl       Date:  1973-08

8.  Human melanoma FUHS-1. Description of a new cell line.

Authors:  V Misgeld; C Meisel
Journal:  Arch Dermatol Forsch       Date:  1975

9.  Adjuvant BCG immunotherapy for malignant melanoma.

Authors:  A H Paterson; D J Willans; L M Jerry; J Hanson; T A McPherson
Journal:  Can Med Assoc J       Date:  1984-10-01       Impact factor: 8.262

10.  Specific immune response in human skin carcinoma.

Authors:  R C Nairn; E P Guli; A P Nind; H K Muller; J M Rolland; C C Minty
Journal:  Br Med J       Date:  1971-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.